Chemomab TherapeuticsCMMB
13F holders, Q3 2024 (September 30)15holders
6new positions
6sold out
1famous investor
$1.57avg. 13F price*
At the end of Q3 2024, 15 institutions reported holding Chemomab Therapeutics Ltd. (CMMB) in their 13F filings, unchanged from Q2 2024. 6 opened new positions and 6 sold out. The largest holders were Orbimed Advisors LLC ($2.7M), Sphera Funds Management LTD. ($1.9M) and Yelin Lapidot Holdings Management Ltd. ($1.3M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Chemomab Therapeutics Ltd.
- CUSIP
- 16385C104
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $3.3M |
| Exits | 6 | $108K |
All 13F filers, Q2 2024 → Q3 2024: 2,494,688 shares bought and 617,677 shares sold, net +1,877,011 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Orbimed Advisors LLC | 0.05% | Reduce -22.3% | 1,741,273 | $2.7M |
| Sphera Funds Management LTD. | 0.31% | New | 1,214,575 | $1.9M |
| Yelin Lapidot Holdings Management Ltd. | 0.21% | New | 809,717 | $1.3M |
| Morgan Stanley | 0.00% | Add +5487.1% | 402,272 | $632K |
| Ikarian Capital, LLC | 0.10% | No change | 213,392 | $335K |
| Two Sigma Securities, LLC | 0.00% | New | 39,939 | $63K |
| Kestra Private Wealth Services, LLC | 0.00% | No change | 31,241 | $49K |
| Rhumbline Advisers | 0.00% | Add +38.7% | 27,573 | $43K |
| Boothbay Fund Management, LLC | 0.00% | No change | 26,529 | $42K |
| XTX Topco Ltd | 0.00% | Add +1.0% | 15,223 | $24K |
| HRT Financial LP | 0.00% | New | 13,579 | $21K |
| Millennium Management | 0.00% | New | 10,565 | $17K |
| UBS Group AG | 0.00% | New | 2,288 | $4K |
| JPMorgan Chase & Co. | 0.00% | Add +110000.0% | 1,101 | $2K |
| Moser Wealth Advisors, LLC | 0.00% | No change | 500 | $785 |
"% of holder's portfolio" is CMMB's weight in each manager's 13F, not the share of Chemomab Therapeutics Ltd. the manager owns.